Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A ...

The U.K. has released a huge repository of children’s genomic data after sequencing blood samples from three large cohorts recruited at birth and followed across three decades. The power of the data ...

Sofinnova Partners raised a whopping €1.2 billion (US$1.26 billion) over the past year to invest in life sciences companies ranging from incubation to later-stage growth, and spanning biotech, med ...

The executive orders (EOs) pouring out of the Trump White House, and the resulting court challenges, continue to pile up, deepening the uncertainty hanging over the life sciences sector and the U.S.

Researchers at the University of California San Diego have uncovered a key mechanism underlying the treatment resistance of ...

The U.S. Patent and Trademark Office has reversed a 2022 agency memorandum on discretionary denials of patent procedures, ...

Avirmax Biopharma Inc. has begun IND-enabling studies of ABI-201, a gene therapy for dry age-related macular degeneration ...

Guillain-Barré syndrome (GBS) is an immune-driven inflammatory disorder of the peripheral nervous system characterized by ...

Epigenetic editing is a promising method for gene regulation in vitro and in vivo, allowing precise control of gene ...

Aminoglycoside antibiotics are essential for treating some severe bacterial infections but are notorious for causing ...

Precision Neuroscience Inc. recently partnered with Beth Israel Deaconess Medical Center to test its brain computer interface ...

The rash of firings at agencies of the Department of Health and Human Services has provoked a Feb. 28 letter from Reps.